3 Best Performing ASX shares in week 48, 6 December 2021
Marc Kennis, December 13, 2021
Best performing ASX shares: Two of the three best performing ASX stocks are (ex) Marc & Stuart’s Top Picks: Neuren Pharmaceuticals (ASX:NEU) was up 117.5% and Revasum (ASX:RVS) went up 39.8%. Sky Network Television (ASX:SKT) rose 36.5% last week and completed the Top 3 Best performing ASX shares.
1. Neuren Pharmaceuticals (ASX: NEU)
Industry: Healthcare
Neuren Pharmaceuticals (ASX: NEU) is an ex-Top Pick on which we made more than 78% earlier this year. It is a biopharmaceutical company developing therapies for brain injury, neurodevelopmental and neurodegenerative disorders. It has two key drug products comprising NNZ-2566 and NNZ-2591 and has operations in New Zealand, Australia and the USA.
Market Cap: $485M
12 month high / low: $4.04 – $1.20

2. Revasum (ASX:RVS)
Industry: Technology
Revasum (ASX:RVS) is a current Top Pick. The company specialises in the design and manufacturing of equipment used to build semiconductors, specifically grinders and polishers for Silicon Carbide (SiC) wafers. SiC chips are used in high voltage applications, like Electric Vehicles and Solar. Revasum’s technology and equipment assists in the advancement of technology for a range of markets and applications including automotive, IoT, 5G, telecommunications, electrification and power devices.
Market Cap: $76M
12 month high / low: $0.88 – $0.21
![]()
3. Sky Network Television (ASX:SKT)
Industry: Consumer
Sky Network Television (ASX:SKT) is a New Zealand broadcasting company that provides pay television services via satellite, media streaming services and broadband internet services. It is also a wholesale channel provider to New Zealand IPTV provider Vodafone.
Market Cap: $405M
12 month high / low: $2.32 – $1.40

Learn more about ASX-listed stocks with
Stocks Down Under!
Subscribe to Stocks Down Under today!
No credit card needed and the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY26
Recent Posts
Moonlight Resources (ASX:ML8) Lists Tomorrow After A$10m IPO: Should You Buy This Gold and Critical Minerals Explorer?
Moonlight Resources (ASX: ML8) will make its ASX debut on 11 December 2025 after completing a A$10 million IPO at…
4DMedical’s Growth Story Gains Airflow in the US Market
4DMedical Finds Its Rhythm 4DMedical (ASX:4DX) climbed 9% today as the company continues to build strong commercial momentum with its…
OpenAI AI Crown Is No Longer Untouchable
OpenAI’s Reign Faces Its First Real Test Many people have heard the headlines claiming that OpenAI is calling a code…